Techglim-M2F Tablet Substitute
by Others
by Others
by AYUR
by Others
by Others
by Others
by AYUR
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
Composition:
GLIMEPIRIDE-2MG + METFORMIN-1000MG
Uses:
Type 2 diabetes mellitus
Medicinal Benefits:
Techglim-M2F Tablet contains Glimepiride and Metformin used in the treatment of type 2 diabetes. Glimepiride stimulates cells in the pancreas that produce insulin which helps to remove sugar from the blood. Metformin PR is a prolonged-release formulation that releases the drug in smaller portions over a longer duration of time. Metformin reduces sugar production by cells in the liver and delays sugar absorption from the intestines. Also, it increases the sensitivity of muscle cells to insulin which enables these cells to remove sugar more effectively from the blood.
Techglim-M2F Tablet contains two antidiabetic drugs, namely: Glimepiride and Metformin. Glimepiride works by stimulating cells in the pancreas that produce insulin which helps to remove sugar from the blood. Metformin PR is a prolonged-release formulation that releases the drug in smaller portions over a longer duration of time. Metformin works by reducing the sugar production by cells in the liver and delays sugar absorption from the intestines. Also, it increases the sensitivity of muscle cells to insulin which enables these cells to remove sugar more effectively from the blood.
You are not recommended to take Techglim-M2F Tablet with phenytoin as it may reduce the effect of Techglim-M2F Tablet and increase blood sugar levels. However, please consult a doctor before using Techglim-M2F Tablet with other medicines.
Techglim-M2F Tablet may increase the risk of low blood sugar levels especially with alcohol intake, exercise more than usual, delay or miss snacks or meal. However, if you experience any signs of low blood pressure such as dizziness, nausea, light-headedness, dehydration or fainting, please consult a doctor.
In type 1 diabetes, the body doesn’t produce insulin as the islet cells (insulin-producing cells) in the pancreas are destroyed completed. In type 2 diabetes, though islet cells are working, the body doesn’t respond to insulin as the body becomes resistant to insulin.
You are not recommended to stop taking Techglim-M2F Tablet on your own as discontinuing Techglim-M2F Tablet suddenly may cause recurring symptoms or worsen the condition. However, if you experience any difficulty while taking Techglim-M2F Tablet , please consult your doctor so that alternative medicine may be prescribed.